Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
November 15, 2001

Walgreen Co Recalls Lantus Insulin Glargine (rDNA origin) Injection

Deerfield, IL  (SafetyAlerts) - The Food and Drug Administration (FDA) said that Walgreen Co. is recalling Lantus Insulin Glargine (rDNA origin) Injection; 100 units/mL.

This is the first public notice of this Class llI recall issued by the FDA.

PRODUCT
Lantus Insulin Glargine (rDNA origin) Injection; 100 units/mL (U-100)in 10 mL vials, 10 vials per pack; NDC #0088-2220-33,

Recall
# D-029-2.

CODE
All lots of Lantus U-100 Insulin distributed to Walgreens pharmacies between 5/2/01 and 9/7/01.

RECALLING FIRM/MANUFACTURER

Recalling Firm:
Walgreen Co., Deerfield, IL, by e-mail on 9/7/01.

Manufacturer:
Aventis Pharma AG Frankfurt am Main, Germany. Firm initiated recall is complete.

REASON
Temperature Abuse-product shipped unrefrigerated by recalling firm.

VOLUME OF PRODUCT IN COMMERCE
38,000 vials.

DISTRIBUTION
Nationwide
.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.